Where to go next with neuroprotection in multiple sclerosis?
Fazekas
Franz
F
D002544:Cerebral Infarction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy / Q000209:etiology; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*
D018696:Neuroprotective Agents